Cmaj Podcasts

Send us a textWith immunotherapy, a cancer patient's immune system is mobilized to attack cancer cells. It's a promising cancer therapy, but it's not without risks and possible complications. In this podcast, Drs. Megan Himmel, Sam Saibil, and Alex Saltman discuss how immune checkpoint inhibitors work, what cancers they work best for, and what to keep in mind when considering this therapy.Dr. Megan Himmel has a PhD in experimental medicine with a focus on T-cell immunology and is currently a PGY4 rheumatology resident at the University of Toronto. Dr. Sam Saibil is a medical oncologist at Princess Margaret Cancer Centre in Toronto and is a PhD scientist in T-cell activation at the Ontario Institute for Cancer Research. Dr. Alex Saltman is a rheumatologist and palliative care physician at Princess Margaret Cancer Centre and at Mount Sinai Hospital in Toronto.The practice article they co-authored is published in CMAJ: www.cmaj.ca/lookup/doi/10.1503/cmaj.191231Podcast transcript: https://www.cmaj.